Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Jun 10 2023

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

This medication is used to treat bowel diseases such as ulcerative colitis and will be manufactured in Ahmedabad, India. The press release highlights that the product had significant annual sales in the United States.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases